Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum

Click to copy article linkArticle link copied!

This article is cited by 150 publications.

1. Nicholas S. Akins, Mohammed F. Salahuddin, Pankaj Pandey, Seong Jong Kim, Fakhri Mahdi, Md Imdadul H. Khan, Emaya M. Moss, Charlie J. Worth, Madeline M. Keane, Amar G. Chittiboyina, Robert J. Doerksen, Jason J. Paris, Hoang V. Le. Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor. ACS Chemical Neuroscience 2023, 14 (5) , 958-976. https://doi.org/10.1021/acschemneuro.2c00806
2. Moonhyuk Kwon, Joseph C. Utomo, Keunwan Park, Cameron A. Pascoe, Sorina Chiorean, Iris Ngo, Kyle A. Pelot, Cheol-Ho Pan, Seon-Won Kim, Philipp Zerbe, John C. Vederas, Dae-Kyun Ro. Cytochrome P450-Catalyzed Biosynthesis of a Dihydrofuran Neoclerodane in Magic Mint (Salvia divinorum). ACS Catalysis 2022, 12 (1) , 777-782. https://doi.org/10.1021/acscatal.1c03691
3. Soumen Chakraborty, Susruta Majumdar. Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide. Biochemistry 2021, 60 (18) , 1381-1400. https://doi.org/10.1021/acs.biochem.0c00629
4. Stone Woo, Ryan A. Shenvi. Natural Product Synthesis through the Lens of Informatics. Accounts of Chemical Research 2021, 54 (5) , 1157-1167. https://doi.org/10.1021/acs.accounts.0c00791
5. R. Bruno Hernández-Alvarado, Abraham Madariaga-Mazón, Alfredo Ortega, Karina Martinez-Mayorga. DARK Classics in Chemical Neuroscience: Salvinorin A. ACS Chemical Neuroscience 2020, 11 (23) , 3979-3992. https://doi.org/10.1021/acschemneuro.0c00608
6. Songye Li, Ming-Qiang Zheng, Mika Naganawa, Hong Gao, Richard Pracitto, Anupama Shirali, Shu-fei Lin, Jo-Ku Teng, Jim Ropchan, Yiyun Huang. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation. Molecular Pharmaceutics 2019, 16 (4) , 1523-1531. https://doi.org/10.1021/acs.molpharmaceut.8b01209
7. Yuzhou Wang, Peter Metz. Total Synthesis of the Neoclerodane Diterpene Salvinorin A via an Intramolecular Diels–Alder Strategy. Organic Letters 2018, 20 (11) , 3418-3421. https://doi.org/10.1021/acs.orglett.8b01357
8. Alexander M. Sherwood, Samuel E. Williamson, Rachel S. Crowley, Logan M. Abbott, Victor W. Day, and Thomas E. Prisinzano . Modular Approach to pseudo-Neoclerodanes as Designer κ-Opioid Ligands. Organic Letters 2017, 19 (19) , 5414-5417. https://doi.org/10.1021/acs.orglett.7b02684
9. Andrew P. Riley, Chad E. Groer, David Young, Amy W. Ewald, Bronwyn M. Kivell, and Thomas E. Prisinzano . Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues. Journal of Medicinal Chemistry 2014, 57 (24) , 10464-10475. https://doi.org/10.1021/jm501521d
10. Michael Heinrich, Barbara Frei Haller, and Marco Leonti . A Perspective on Natural Products Research and Ethnopharmacology in Mexico: The Eagle and the Serpent on the Prickly Pear Cactus. Journal of Natural Products 2014, 77 (3) , 678-689. https://doi.org/10.1021/np4009927
11. Thomas E. Prisinzano . Neoclerodanes as Atypical Opioid Receptor Ligands. Journal of Medicinal Chemistry 2013, 56 (9) , 3435-3443. https://doi.org/10.1021/jm400388u
12. Sean C. Butler and Craig J. Forsyth . A Stereoconvergent Intramolecular Diels–Alder Cycloaddition Related to the Construction of the Decalin Core of neo-Clerodane Diterpenoids. The Journal of Organic Chemistry 2013, 78 (8) , 3895-3907. https://doi.org/10.1021/jo400029u
13. Yi-Bing Wu, Zhi-Yu Ni, Qing-Wen Shi, Mei Dong, Hiromasa Kiyota, Yu-Cheng Gu, and Bin Cong . Constituents from Salvia Species and Their Biological Activities. Chemical Reviews 2012, 112 (11) , 5967-6026. https://doi.org/10.1021/cr200058f
14. Anthony Lozama, Christopher W. Cunningham, Michael J. Caspers, Justin T. Douglas, Christina M. Dersch, Richard B. Rothman, and Thomas E. Prisinzano . Opioid Receptor Probes Derived from Cycloaddition of the Hallucinogen Natural Product Salvinorin A. Journal of Natural Products 2011, 74 (4) , 718-726. https://doi.org/10.1021/np1007872
15. Feng Yan, Ruslan V. Bikbulatov, Viorel Mocanu, Nedyalka Dicheva, Carol E. Parker, William C. Wetsel, Philip D. Mosier, Richard B. Westkaemper, John A. Allen, Jordan K. Zjawiony and Bryan L. Roth . Structure-Based Design, Synthesis, and Biochemical and Pharmacological Characterization of Novel Salvinorin A Analogues as Active State Probes of the κ-Opioid Receptor. Biochemistry 2009, 48 (29) , 6898-6908. https://doi.org/10.1021/bi900605n
16. Lukasz M. Kutrzeba, Daneel Ferreira and Jordan K. Zjawiony. Salvinorins J from Salvia divinorum: Mutarotation in the Neoclerodane System. Journal of Natural Products 2009, 72 (7) , 1361-1363. https://doi.org/10.1021/np900181q
17. Thomas E. Prisinzano. Natural Products as Tools for Neuroscience: Discovery and Development of Novel Agents to Treat Drug Abuse. Journal of Natural Products 2009, 72 (3) , 581-587. https://doi.org/10.1021/np8005748
18. Ylva E. Bergman, Roger Mulder and Patrick Perlmutter . Total Synthesis of 20-Norsalvinorin A. 1. Preparation of a Key Intermediate. The Journal of Organic Chemistry 2009, 74 (6) , 2589-2591. https://doi.org/10.1021/jo802623n
19. Thomas E. Prisinzano and Richard B. Rothman . Salvinorin A Analogs as Probes in Opioid Pharmacology. Chemical Reviews 2008, 108 (5) , 1732-1743. https://doi.org/10.1021/cr0782269
20. Kevin Tidgewell, Chad E. Groer, Wayne W. Harding, Anthony Lozama, Matthew Schmidt, Alfred Marquam, Jessica Hiemstra, John S. Partilla, Christina M. Dersch, Richard B. Rothman, Laura M. Bohn and Thomas E. Prisinzano . Herkinorin Analogues with Differential β-Arrestin-2 Interactions. Journal of Medicinal Chemistry 2008, 51 (8) , 2421-2431. https://doi.org/10.1021/jm701162g
21. Masato Nozawa,, Yuhki Suka,, Takashi Hoshi,, Toshio Suzuki, and, Hisahiro Hagiwara. Total Synthesis of the Hallucinogenic Neoclerodane Diterpenoid Salvinorin A. Organic Letters 2008, 10 (7) , 1365-1368. https://doi.org/10.1021/ol800101v
22. Denise S. Simpson,, Peter L. Katavic,, Anthony Lozama,, Wayne W. Harding,, Damon Parrish,, Jeffrey R. Deschamps,, Christina M. Dersch,, John S. Partilla,, Richard B. Rothman,, Hernan Navarro, and, Thomas E. Prisinzano. Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum:  Preparation and Opioid Receptor Activity of Salvinicin Analogues. Journal of Medicinal Chemistry 2007, 50 (15) , 3596-3603. https://doi.org/10.1021/jm070393d
23. Osamu Shirota,, Kumi Nagamatsu, and, Setsuko Sekita. Neo-clerodane Diterpenes from the Hallucinogenic Sage Salvia divinorum. Journal of Natural Products 2006, 69 (12) , 1782-1786. https://doi.org/10.1021/np060456f
24. Kevin Tidgewell,, Wayne W. Harding,, Anthony Lozama,, Howard Cobb,, Kushal Shah,, Pavitra Kannan,, Christina M. Dersch,, Damon Parrish,, Jeffrey R. Deschamps,, Richard B. Rothman, and, Thomas E. Prisinzano. Synthesis of Salvinorin A Analogues as Opioid Receptor Probes. Journal of Natural Products 2006, 69 (6) , 914-918. https://doi.org/10.1021/np060094b
25. Wayne W. Harding,, Matthew Schmidt,, Kevin Tidgewell,, Pavitra Kannan,, Kenneth G. Holden,, Brian Gilmour,, Hernan Navarro,, Richard B. Rothman, and, Thomas E. Prisinzano. Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum:  Semisynthesis of Salvinicins A and B and Other Chemical Transformations of Salvinorin A. Journal of Natural Products 2006, 69 (1) , 107-112. https://doi.org/10.1021/np050398i
26. Thomas A. Munro,, Glenn W. Goetchius,, Bryan L. Roth,, Timothy A. Vortherms, and, Mark A. Rizzacasa. Autoxidation of Salvinorin A under Basic Conditions. The Journal of Organic Chemistry 2005, 70 (24) , 10057-10061. https://doi.org/10.1021/jo051813e
27. Wayne W. Harding,, Kevin Tidgewell,, Nathan Byrd,, Howard Cobb,, Christina M. Dersch,, Eduardo R. Butelman,, Richard B. Rothman, and, Thomas E. Prisinzano. Neoclerodane Diterpenes as a Novel Scaffold for μ Opioid Receptor Ligands. Journal of Medicinal Chemistry 2005, 48 (15) , 4765-4771. https://doi.org/10.1021/jm048963m
28. Wayne W. Harding,, Kevin Tidgewell,, Matthew Schmidt,, Kushal Shah,, Christina M. Dersch,, John Snyder,, Damon Parrish,, Jeffrey R. Deschamps,, Richard B. Rothman, and, Thomas E. Prisinzano. Salvinicins A and B, New Neoclerodane Diterpenes from Salvia divinorum. Organic Letters 2005, 7 (14) , 3017-3020. https://doi.org/10.1021/ol0510522
29. Feng Yan,, Philip D. Mosier,, Richard B. Westkaemper,, Jeremy Stewart,, Jordan K. Zjawiony,, Timothy A. Vortherms,, Douglas J. Sheffler, and, Bryan L. Roth. Identification of the Molecular Mechanisms by Which the Diterpenoid Salvinorin A Binds to κ-Opioid Receptors. Biochemistry 2005, 44 (24) , 8643-8651. https://doi.org/10.1021/bi050490d
30. Hisahiro Hagiwara,, Kenta Hamano,, Masato Nozawa,, Takashi Hoshi,, Toshio Suzuki, and, Fusao Kido. The First Total Synthesis of (−)-Methyl Barbascoate. The Journal of Organic Chemistry 2005, 70 (6) , 2250-2255. https://doi.org/10.1021/jo0478499
31. Thomas A. Munro,, Mark A. Rizzacasa,, Bryan L. Roth,, Beth A. Toth, and, Feng Yan. Studies toward the Pharmacophore of Salvinorin A, a Potent κ Opioid Receptor Agonist. Journal of Medicinal Chemistry 2005, 48 (2) , 345-348. https://doi.org/10.1021/jm049438q
32. Andrea K. Bigham,, Thomas A. Munro,, Mark A. Rizzacasa, and, Roy M. Robins-Browne. Divinatorins A−C, New Neoclerodane Diterpenoids from the Controlled Sage Salvia divinorum. Journal of Natural Products 2003, 66 (9) , 1242-1244. https://doi.org/10.1021/np030313i
33. Thomas A. Munro and, Mark A. Rizzacasa. Salvinorins D−F, New Neoclerodane Diterpenoids from Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A. Journal of Natural Products 2003, 66 (5) , 703-705. https://doi.org/10.1021/np0205699
34. Leander J. Valdés III,, Hui-Ming Chang,, Daniel C. Visger, and, Masato Koreeda. Salvinorin C, a New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican Mint Salvia divinorum. Organic Letters 2001, 3 (24) , 3935-3937. https://doi.org/10.1021/ol016820d
35. Iris Ngo, Rahul Kumar, Liang Li, Seon‐Won Kim, Moonhyuk Kwon, Dae‐Kyun Ro. Identification of clerodane diterpene modifying cytochrome P450 ( CYP728D26 ) in Salvia divinorum ‐ en route to psychotropic salvinorin A biosynthesis. Physiologia Plantarum 2024, 176 (5) https://doi.org/10.1111/ppl.14569
36. P.G. Cozzi, A. Gualandi, F. Calogero, E. Pinosa, D. Corbisiero. Organochromium Reagents. 2024https://doi.org/10.1016/B978-0-323-96025-0.00035-1
37. Majid M. Heravi, Batoul Alipour, Vahideh Zadsirjan, Masoume Malmir. Robinson Annulation Applied to the Total Synthesis of Natural Products. Asian Journal of Organic Chemistry 2023, 12 (3) https://doi.org/10.1002/ajoc.202200668
38. Susanta Kumar Manna, Soumen Giri, Sampa Mondal, Rabindra Nath Sana, Aroop Kumar Samal, Arabinda Mandal. A Detailed Review on C ‐Fused Furan/3,4‐Fused Furan Analog and its Potential Applications. ChemistrySelect 2023, 8 (1) https://doi.org/10.1002/slct.202203150
39. Federica Santino, Luca Gentilucci. Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects. Molecules 2023, 28 (1) , 346. https://doi.org/10.3390/molecules28010346
40. Bharathi Avula, Ji-Yeong Bae, Amar G. Chittiboyina, Yan-Hong Wang, Mei Wang, Radhakrishnan Srivedavyasasri, Zulfiqar Ali, Jing Li, Charles Wu, Ikhlas A. Khan. Comparative analysis of five Salvia species using LC-DAD-QToF. Journal of Pharmaceutical and Biomedical Analysis 2022, 209 , 114520. https://doi.org/10.1016/j.jpba.2021.114520
41. Rashmi Saxena Pal, Yogendra Pal, Deepti Katiyar, Kanav Khera, Saranya Punniyakotti. Herbal Drug Addiction: Latest Information on Trends and Outlines. Pharmacophore 2022, 13 (3) , 86-90. https://doi.org/10.51847/GT5jWqVGCa
42. Cooper S. Jamieson, Joshua Misa, Yi Tang, John M. Billingsley. Biosynthesis and synthetic biology of psychoactive natural products. Chemical Society Reviews 2021, 50 (12) , 6950-7008. https://doi.org/10.1039/D1CS00065A
43. Patrick Zimdars, Yuzhou Wang, Peter Metz. A Protecting‐Group‐Free Synthesis of (−)‐Salvinorin A. Chemistry – A European Journal 2021, 27 (29) , 7968-7973. https://doi.org/10.1002/chem.202100560
44. Christopher R. McCurdy, Thomas E. Prisinzano. Opioid Receptor Ligands. 2021, 1-171. https://doi.org/10.1002/0471266949.bmc251.pub2
45. Vera Lukić, Ružica Micić, Biljana Arsić, Bojan Nedović, Živana Radosavljević. Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs. Open Chemistry 2021, 19 (1) , 60-106. https://doi.org/10.1515/chem-2021-0196
46. Alfredo Fabrizio Lo Faro, Annagiulia Di Trana, Nunzia La Maida, Adriano Tagliabracci, Raffaele Giorgetti, Francesco Paolo Busardò. Biomedical analysis of New Psychoactive Substances (NPS) of natural origin. Journal of Pharmaceutical and Biomedical Analysis 2020, 179 , 112945. https://doi.org/10.1016/j.jpba.2019.112945
47. Jeroen S. Dickschat. Biosynthesis of Diterpenoid Natural Products. 2020, 506-552. https://doi.org/10.1016/B978-0-12-409547-2.14624-4
48. Naoto Okutomi, Akinobu Matsuzawa, Kazuyuki Sugita. Diastereoselective Total Syntheses of (±)‐Caseabalansin A and (±)‐18‐Epicaseabalansin A via Intramolecular Robinson‐type Annulation. Chemistry – An Asian Journal 2019, 14 (12) , 2077-2081. https://doi.org/10.1002/asia.201900368
49. Jordan K. Zjawiony, Antônio S. Machado, Ricardo Menegatti, Paulo C. Ghedini, Elson A. Costa, Gustavo R. Pedrino, Scott E. Lukas, Octávio L. Franco, Osmar N. Silva, James O. Fajemiroye. Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs. Frontiers in Psychiatry 2019, 10 https://doi.org/10.3389/fpsyt.2019.00157
50. Bronwyn M. Kivell, Kelly F. Paton, Nitin Kumar, Aashish S. Morani, Aimee Culverhouse, Amy Shepherd, Susan A. Welsh, Andrew Biggerstaff, Rachel S. Crowley, Thomas E. Prisinzano. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents. Molecules 2018, 23 (10) , 2602. https://doi.org/10.3390/molecules23102602
51. Shun Hirasawa, Min Cho, Tarsis F. Brust, Jeremy J. Roach, Laura M. Bohn, Ryan A. Shenvi. O6C-20-nor-salvinorin A is a stable and potent KOR agonist. Bioorganic & Medicinal Chemistry Letters 2018, 28 (16) , 2770-2772. https://doi.org/10.1016/j.bmcl.2018.01.055
52. Ana Elda Maqueda. The Use of Salvia divinorum from a Mazatec Perspective. 2018, 55-70. https://doi.org/10.1007/978-3-319-76720-8_4
53. Angélica Faleiros da Silva Maia, Leonardo da Silva Neto, Frederico Duarte Garcia, Rosemeire Brondi Alves, Ângelo de Fátima. Natural Products in Addiction Treatment. 2018, 415-434. https://doi.org/10.1016/B978-0-12-809593-5.00011-2
54. Seda Damla Hatipoglu, Burhanettin Yalcinkaya, Muslum Akgoz, Turan Ozturk, Ahmet C. Goren, Gulacti Topcu. Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species. Phytochemical Analysis 2017, 28 (6) , 541-549. https://doi.org/10.1002/pca.2703
55. André Cruz, Sara Domingos, Eugenia Gallardo, Ana Martinho. A unique natural selective kappa -opioid receptor agonist, salvinorin A, and its roles in human therapeutics. Phytochemistry 2017, 137 , 9-14. https://doi.org/10.1016/j.phytochem.2017.02.001
56. Xiaoyue Chen, Anna Berim, Franck E. Dayan, David R. Gang. A (–)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum. Journal of Experimental Botany 2017, 68 (5) , 1109-1122. https://doi.org/10.1093/jxb/erw493
57. Nathan J. Line, Aaron C. Burns, Sean C. Butler, Jerry Casbohm, Craig J. Forsyth. Total Synthesis of (−)‐Salvinorin A. Chemistry – A European Journal 2016, 22 (50) , 17983-17986. https://doi.org/10.1002/chem.201604853
58. María Eva González-Trujano, Fernando Brindis, Edith López-Ruiz, Ignacio Ramírez-Salado, Adrián Martínez, Francisco Pellicer. Depressant Effects of Salvia divinorum Involve Disruption of Physiological Sleep. Phytotherapy Research 2016, 30 (7) , 1137-1145. https://doi.org/10.1002/ptr.5617
59. Ana Elda Maqueda, Marta Valle, Peter H. Addy, Rosa Maria Antonijoan, Montserrat Puntes, Jimena Coimbra, Maria Rosa Ballester, Maite Garrido, Mireia González, Judit Claramunt, Steven Barker, Izabela Lomnicka, Marian Waguespack, Matthew W. Johnson, Roland R. Griffiths, Jordi Riba. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. International Journal of Neuropsychopharmacology 2016, 19 (7) , pyw016. https://doi.org/10.1093/ijnp/pyw016
60. Cláudia Margalho, Francisco Corte-Real, Manuel López-Rivadulla, Eugenia Gallardo. Salvia Divinorum : Toxicological Aspects and Analysis in Human Biological Specimens. Bioanalysis 2016, 8 (13) , 1415-1425. https://doi.org/10.4155/bio-2016-0067
61. M. Akaberi, M. Iranshahi, S. Mehri. Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology. Phytotherapy Research 2016, 30 (6) , 878-893. https://doi.org/10.1002/ptr.5599
62. Achla Gupta, Ivone Gomes, Erin N. Bobeck, Amanda K. Fakira, Nicholas P. Massaro, Indrajeet Sharma, Adrien Cavé, Heidi E. Hamm, Joseph Parello, Lakshmi A. Devi. Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity. Proceedings of the National Academy of Sciences 2016, 113 (21) , 6041-6046. https://doi.org/10.1073/pnas.1521825113
63. Adam W. Keasling, Jordan K. Zjawiony. The Plant Salvia divinorum (Lamiaceae)—Chemistry and Pharmacology. 2016, 551-560. https://doi.org/10.1016/B978-0-12-800212-4.00051-0
64. Rongtao Li, Susan L. Morris-Natschke, Kuo-Hsiung Lee. Clerodane diterpenes: sources, structures, and biological activities. Natural Product Reports 2016, 33 (10) , 1166-1226. https://doi.org/10.1039/C5NP00137D
65. Aurélien Blanc, Valérie Bénéteau, Jean-Marc Weibel, Patrick Pale. Silver & gold-catalyzed routes to furans and benzofurans. Organic & Biomolecular Chemistry 2016, 14 (39) , 9184-9205. https://doi.org/10.1039/C6OB01468B
66. Michael S Placzek, Genevieve C Van de Bittner, Hsiao-Ying Wey, Scott E Lukas, Jacob M Hooker. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET. Neuropsychopharmacology 2015, 40 (13) , 2865-2872. https://doi.org/10.1038/npp.2015.159
67. Rafael Hernández-Bello, Rosa Virginia García-Rodríguez, Karlina García-Sosa, Luis Manuel Peña-Rodríguez, Maribel Vázquez-Hernández, Fernando Rafael Ramos-Morales, Olivia Corcoran, Alberto Sánchez-Medina. Salvinorin A content in legal high products of Salvia divinorum sold in Mexico. Forensic Science International 2015, 249 , 197-201. https://doi.org/10.1016/j.forsciint.2015.01.038
68. Ivan Casselman, Catherine J. Nock, Hans Wohlmuth, Robert P. Weatherby, Michael Heinrich. From local to global—Fifty years of research on Salvia divinorum. Journal of Ethnopharmacology 2014, 151 (2) , 768-783. https://doi.org/10.1016/j.jep.2013.11.032
69. Cláudia Margalho, Eugenia Gallardo, Alice Castanheira, Duarte Nuno Vieira, Manuel López-Rivadulla, Francisco Corte Real. A validated procedure for detection and quantitation of salvinorin a in pericardial fluid, vitreous humor, whole blood and plasma using solid phase extraction and gas chromatography–mass spectrometry. Journal of Chromatography A 2013, 1304 , 203-210. https://doi.org/10.1016/j.chroma.2013.07.031
70. Hisahiro Hagiwara, Naomi Honma, Kimihiko Kinugawa, Shota Sato, Takashi Hoshi, Toshio Suzuki. Second Generation Synthesis of the Neo-Clerodane Diterpenoid Methyl Barbascoate. Natural Product Communications 2013, 8 (7) https://doi.org/10.1177/1934578X1300800706
71. Eduardo Estrada-Castillón, Brianda Elizabeth Soto-Mata, Miriam Garza-López, José Ángel Villarreal-Quintanilla, Javier Jiménez-Pérez, Marisela Pando-Moreno, Jaime Sánchez-Salas, Laura Scott-Morales, Mauricio Cotera-Correa. Medicinal plants in the southern region of the State of Nuevo León, México. Journal of Ethnobiology and Ethnomedicine 2012, 8 (1) https://doi.org/10.1186/1746-4269-8-45
72. Kimberly M. Lovell, Tamara Vasiljevik, Juan J. Araya, Anthony Lozama, Katherine M. Prevatt-Smith, Victor W. Day, Christina M. Dersch, Richard B. Rothman, Eduardo R. Butelman, Mary Jeanne Kreek, Thomas E. Prisinzano. Semisynthetic neoclerodanes as kappa opioid receptor probes. Bioorganic & Medicinal Chemistry 2012, 20 (9) , 3100-3110. https://doi.org/10.1016/j.bmc.2012.02.040
73. HR Sumnall, F Measham, SD Brandt, JC Cole. Salvia divinorum use and phenomenology: results from an online survey. Journal of Psychopharmacology 2011, 25 (11) , 1496-1507. https://doi.org/10.1177/0269881110385596
74. Christopher W. Cunningham, Richard B. Rothman, Thomas E. Prisinzano. Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A. Pharmacological Reviews 2011, 63 (2) , 316-347. https://doi.org/10.1124/pr.110.003244
75. John E. Mendelson, Jeremy R. Coyle, Juan Carlos Lopez, Matthew J. Baggott, Keith Flower, E. Thomas Everhart, Thomas A. Munro, Gantt P. Galloway, Bruce M. Cohen. Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial. Psychopharmacology 2011, 214 (4) , 933-939. https://doi.org/10.1007/s00213-010-2103-5
76. Hisahiro Hagiwara, Takashi Nojima, Yuhki Suka, Takashi Hoshi, Toshio Suzuki. First Total Synthesis of the Neo-Clerodane Diterpenoid Salvinorin F. Natural Product Communications 2011, 6 (3) https://doi.org/10.1177/1934578X1100600306
77. Katherine M. Prevatt-Smith, Kimberly M. Lovell, Denise S. Simpson, Victor W. Day, Justin T. Douglas, Peter Bosch, Christina M. Dersch, Richard B. Rothman, Bronwyn Kivell, Thomas E. Prisinzano. Potential drug abuse therapeutics derived from the hallucinogenic natural product salvinorin A. MedChemComm 2011, 2 (12) , 1217. https://doi.org/10.1039/c1md00192b
78. David Y.W. Lee, Lu Yang, Wei Xu, Gang Deng, Lin Guo, Lee-Yuan Liu-Chen. Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A. Bioorganic & Medicinal Chemistry Letters 2010, 20 (19) , 5749-5752. https://doi.org/10.1016/j.bmcl.2010.08.001
79. Matthew J. Baggott, Earth Erowid, Fire Erowid, Gantt P. Galloway, John Mendelson. Use patterns and self-reported effects of Salvia divinorum: An internet-based survey. Drug and Alcohol Dependence 2010, 111 (3) , 250-256. https://doi.org/10.1016/j.drugalcdep.2010.05.003
80. Zhongze Ma, Gang Deng, Ronghua Dai, Wei Xu, Lee-Yuan Liu-Chen, David Y.W. Lee. Thermal degradation products derived from the smoke of Salvia divinorum leaves. Tetrahedron Letters 2010, 51 (41) , 5480-5482. https://doi.org/10.1016/j.tetlet.2010.08.033
81. Christopher R. McCurdy, Thomas E. Prisinzano. Opioid Receptor Ligands. 2010, 569-736. https://doi.org/10.1002/0471266949.bmc251
82. Don Antoine Lanfranchi, Christophe Bour, Bastien Boff, Gilles Hanquet. Ring‐Closing of 1,7‐ and 1,8‐Enynes of Propargylic O , O ‐Acetals by Ruthenium‐Catalysed Intramolecular Metathesis. European Journal of Organic Chemistry 2010, 2010 (27) , 5232-5247. https://doi.org/10.1002/ejoc.201000305
83. Zhongze Ma, Gang Deng, David Y.W. Lee. Novel neoclerodane diterpene derivatives from the smoke of salvinorin A. Tetrahedron Letters 2010, 51 (39) , 5207-5209. https://doi.org/10.1016/j.tetlet.2010.07.144
84. D. Matthew Walentiny, Robert E. Vann, Jonathan A. Warner, Lindsey S. King, Herbert H. Seltzman, Hernán A. Navarro, Charles E. Twine, Brian F. Thomas, Anne F. Gilliam, Brian P. Gilmour, F. Ivy Carroll, Jenny L. Wiley. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology 2010, 210 (2) , 275-284. https://doi.org/10.1007/s00213-010-1827-6
85. James R. Hanson. Natural Products from the Hallucinogenic Sage. Science Progress 2010, 93 (2) , 171-180. https://doi.org/10.3184/003685010X12626983776947
86. Donna L. McGovern, Philip D. Mosier, Bryan L. Roth, Richard B. Westkaemper. CoMFA analyses of C-2 position Salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity. Journal of Molecular Graphics and Modelling 2010, 28 (7) , 612-625. https://doi.org/10.1016/j.jmgm.2009.12.008
87. Kimberly M. Lovell, Katherine M. Prevatt-Smith, Anthony Lozama, Thomas E. Prisinzano. Synthesis of Neoclerodane Diterpenes and Their Pharmacological Effects. 2010, 141-185. https://doi.org/10.1007/128_2010_82
88. Gordon M. Cragg, David J. Newman, David G.I. Kingston. Terrestrial Plants as a Source of Novel Pharmaceutical Agents. 2010, 5-39. https://doi.org/10.1016/B978-008045382-8.00033-2
89. Katherine M. Prevatt-Smith, Thomas E. Prisinzano. New therapeutic potential for psychoactive natural products. Nat. Prod. Rep. 2010, 27 (1) , 23-31. https://doi.org/10.1039/B912196J
90. Anthony Lozama, Thomas E. Prisinzano. Chemical methods for the synthesis and modification of neoclerodane diterpenes. Bioorganic & Medicinal Chemistry Letters 2009, 19 (18) , 5490-5495. https://doi.org/10.1016/j.bmcl.2009.07.069
91. Will C. McClatchey, Gail B. Mahady, Bradley C. Bennett, Laura Shiels, Valentina Savo. Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources. Pharmacology & Therapeutics 2009, 123 (2) , 239-254. https://doi.org/10.1016/j.pharmthera.2009.04.002
92. Hisahiro Hagiwara, Yuhki Suka, Takashi Nojima, Takashi Hoshi, Toshio Suzuki. Second-generation synthesis of salvinorin A. Tetrahedron 2009, 65 (25) , 4820-4825. https://doi.org/10.1016/j.tet.2009.04.053
93. Kimberly M Lovell, Denise S Simpson, Christopher W Cunningham, Thomas E Prisinzano. Utilizing Nature as a Source of New Probes for Opioid Pharmacology. Future Medicinal Chemistry 2009, 1 (2) , 285-301. https://doi.org/10.4155/fmc.09.22
94. Lisa E. Baker, John J. Panos, Bryan A. Killinger, Mary M. Peet, Lisa M. Bell, Larissa A. Haliw, Sheryl L. Walker. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology 2009, 203 (2) , 203-211. https://doi.org/10.1007/s00213-008-1458-3
95. Eduardo R. Butelman, Thomas E. Prisinzano, Haiteng Deng, Szymon Rus, Mary Jeanne Kreek. Unconditioned Behavioral Effects of the Powerful κ-Opioid Hallucinogen Salvinorin A in Nonhuman Primates: Fast Onset and Entry into Cerebrospinal Fluid. The Journal of Pharmacology and Experimental Therapeutics 2009, 328 (2) , 588-597. https://doi.org/10.1124/jpet.108.145342
96. Denise S. Simpson, Kimberly M. Lovell, Anthony Lozama, Nina Han, Victor W. Day, Christina M. Dersch, Richard B. Rothman, Thomas E. Prisinzano. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors. Organic & Biomolecular Chemistry 2009, 7 (18) , 3748. https://doi.org/10.1039/b905148a
97. Pieter Beerepoot, Vincent Lam, Alice Luu, Bernice Tsoi, Daniel Siebert, Henry Szechtman. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole. Neuroscience Letters 2008, 446 (2-3) , 101-104. https://doi.org/10.1016/j.neulet.2008.09.035
98. R Capasso, F Borrelli, M G Cascio, G Aviello, K Huben, J K Zjawiony, P Marini, B Romano, V Di Marzo, F Capasso, A A Izzo. Inhibitory effect of salvinorin A, from Salvia divinorum , on ileitis‐induced hypermotility: cross‐talk between κ‐opioid and cannabinoid CB 1 receptors. British Journal of Pharmacology 2008, 155 (5) , 681-689. https://doi.org/10.1038/bjp.2008.294
99. Kenji Tsujikawa, Kenji Kuwayama, Hajime Miyaguchi, Tatsuyuki Kanamori, Yuko T. Iwata, Takemi Yoshida, Hiroyuki Inoue. Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan. Forensic Science International 2008, 180 (2-3) , 105-109. https://doi.org/10.1016/j.forsciint.2008.07.008
100. Zhongze Ma, David Y.W. Lee. Synthesis of deacetyl-1,10-didehydrosalvinorin G. Tetrahedron Letters 2008, 49 (11) , 1782-1785. https://doi.org/10.1016/j.tetlet.2008.01.065